MIA is a potential biomarker for tumour load in neurofibromatosis type 1

被引：0
|
作者：
Mateusz Kolanczyk
Victor Mautner
Nadine Kossler
Rosa Nguyen
Jirko Kühnisch
Tomasz Zemojtel
Aleksander Jamsheer
Eike Wegener
Boris Thurisch
Sigrid Tinschert
Nikola Holtkamp
Su-Jin Park
Patricia Birch
David Kendler
Anja Harder
Stefan Mundlos
Lan Kluwe
机构：
[1] Institute of Medical Genetics,Development and Disease Group
[2] Charité,Department of Oral and Maxillofacial Surgery, Department of Neurology
[3] Universitätsmedizin Berlin,Department of Computational Molecular Biology
[4] Humboldt University,Department of Medical Genetics
[5] Max Planck Institute for Molecular Genetics,Medizinische Fakultät Carl Gustav Carus
[6] University Hospital Hamburg-Eppendorf,CVK
[7] Max Planck Institute for Molecular Genetics,Berlin Center for Regenerative Therapies
[8] Center for Medical Genetics in Poznań,Department of Medical Genetics
[9] Medical University of Poznan,Faculty of Medicine
[10] Institut für Klinische Genetik,German Cancer Research Center
[11] Technische Universität Dresden,undefined
[12] Institute of Neuropathology,undefined
[13] Charité-Universitätsmedizin Berlin,undefined
[14] Charité-Universitätsmedizin Berlin,undefined
[15] University of British Columbia,undefined
[16] University of British Columbia,undefined
[17] Institute of Neuropathology,undefined
[18] University Hospital Münster,undefined
[19] Im Neuenheimer Feld,undefined
来源：
BMC Medicine | / 9卷
关键词：
Neurofibroma; Malignant Peripheral Nerve Sheath Tumour; Subcutaneous Tumour; Tumour Load; Plexiform Neurofibroma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MIA is a potential biomarker for tumour load in neurofibromatosis type 1
    Kolanczyk, Mateusz
    Mautner, Victor
    Kossler, Nadine
    Nguyen, Rosa
    Kuehnisch, Jirko
    Zemojtel, Tomasz
    Jamsheer, Aleksander
    Wegener, Eike
    Thurisch, Boris
    Tinschert, Sigrid
    Holtkamp, Nikola
    Park, Su-Jin
    Birch, Patricia
    Kendler, David
    Harder, Anja
    Mundlos, Stefan
    Kluwe, Lan
    [J]. BMC MEDICINE, 2011, 9
  • [2] Serum biomarker in neurofibromatosis type 1
    Yoshida, Yuichi
    Furumura, Minao
    Tahira, Makoto
    Horie, Takashi
    Yamamoto, Osamu
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2012, 67 (02) : 155 - 158
  • [3] Bilateral testicular tumour in neurofibromatosis type 1
    Kume, H
    Tachikawa, T
    Teramoto, S
    Isurugi, K
    Kitamura, T
    [J]. LANCET, 2001, 357 (9253): : 395 - 396
  • [4] Neuroendocrine tumour in a patient with neurofibromatosis type 1 and HIV
    Hiesgen, Juliane
    Variava, Ebrahim
    [J]. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2015, 16 (01) : 135 - 138
  • [5] Type 1 neurofibromatosis, mouse models and tumour development
    Giovannini, M
    [J]. M S-MEDECINE SCIENCES, 2000, 16 (6-7): : 820 - 822
  • [6] Neurofibromatosis type 1 — a model for nervous system tumour formation?
    Joshua B. Rubin
    David H. Gutmann
    [J]. Nature Reviews Cancer, 2005, 5 : 557 - 564
  • [7] Intramedullary spinal cord tumour associated with neurofibromatosis type 1
    T. Yagi
    K. Ohata
    M. Haque
    A. Hakuba
    [J]. Acta Neurochirurgica, 1997, 139 : 1055 - 1060
  • [8] Primitive Neuroectodermal Tumour: A Rare Association with Neurofibromatosis Type 1
    Gumus, Hatice
    Gumus, Metehan
    Firat, Ugur
    Onder, Hakan
    Inci, Fatih
    [J]. JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 (01) : 114 - 116
  • [9] Gastric carcinoid tumour and neurofibromatosis type 1: a case report
    Stewart, W
    Traynor, JP
    Shah, AA
    Balsitis, M
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (05) : 526 - 527
  • [10] Intramedullary spinal cord tumour associated with neurofibromatosis type 1
    Yagi, T
    Ohata, K
    Haque, M
    Hakuba, A
    [J]. ACTA NEUROCHIRURGICA, 1997, 139 (11) : 1055 - 1060
12345